Basal Insulin Degludec and Glycemic Control Compared to Aspart Via Insulin Pump in Type 1 Diabetes (BIGLEAP): A Single-Center, Open-Label, Randomized, Crossover Trial.

Lane, Wendy S; Weinrib, Stephen L; Lawrence, Michael J; Lane, Benjamin C; Jarrett, Ryan T

Lane, Wendy S; Weinrib, Stephen L; Lawrence, Michael J; Lane, Benjamin C; Jarrett, Ryan T.

Afiliación

Lane WS; Mountain Diabetes and Endocrine Center, Asheville, North Carolina. Electronic address: mountaindiabetes@msn.com.
Weinrib SL; Mountain Diabetes and Endocrine Center, Asheville, North Carolina.
Lawrence MJ; Mountain Diabetes and Endocrine Center, Asheville, North Carolina.
Lane BC; Department of Data Science, Vanderbilt University, Nashville, Tennessee.
Jarrett RT; Department of Biostatistics, Vanderbilt University, Nashville, Tennessee.

Endocr Pract ; 28(2): 165-172, 2022 Feb.

Article en En | MEDLINE | ID: mdl-34763071

Asunto(s)

Diabetes Mellitus Tipo 1; Adulto; Glucemia; Automonitorización de la Glucosa Sanguínea; Estudios Cruzados; Diabetes Mellitus Tipo 1/tratamiento farmacológico; Hemoglobina Glucada/análisis; Control Glucémico; Humanos; Hipoglucemiantes; Insulina; Insulina Aspart; Insulina de Acción Prolongada

Palabras clave

continuous glucose monitoring; glycemic control; hypoglycemia; insulin degludec; insulin pump therapy; type 1 diabetes

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 1 Tipo de estudio: Clinical_trials Límite: Adult / Humans Idioma: En Revista: Endocr Pract Asunto de la revista: ENDOCRINOLOGIA Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google